Adjuvant Use of Neostigmine in Sepsis and Septic Shock.

Clinical trial NCT04130230 · COMPLETED

Trial details

NCT number: NCT04130230
Sponsor: Mansoura University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis, Septic Shock

Start date: 2019-03-06
Primary completion: 2021-08-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.